Skip to main content
. 2012 Jan 19;131(7):1145–1152. doi: 10.1007/s00439-012-1141-y

Table 3.

Association tests of PNPLA3 rs738409 in different NAFLD spectrum

NAFLD spectrum G allele frequency Unadjusted Adjusted for age, gender and ethnicity
p value OR (CI) p value OR (CI)
Control as reference
NAFLD vs. control
 Overall 0.45 vs. 0.24 <0.0001 2.34 (1.69–3.24) <0.0001 2.23 (1.60–3.11)
 Malays 0.42 vs. 0.24 0.005 2.05 (1.25–3.35) 0.007 2.00 (1.21–3.21)
 Chinese 0.49 vs. 0.32 0.018 1.94 (1.12–3.37) 0.02 1.93 (1.11–3.36)
 Indians 0.44 vs. 0.18 0.001 3.51 (1.69–7.26) 0.001 3.50 (1.67–7.33)
Simple steatosis vs. control 0.35 vs. 0.24 0.083 1.61 (0.94–2.75) 0.272 1.37 (0.78–2.42)
All NASH vs. control 0.48 vs. 0.24 <0.0001 2.64 (1.85–3.75) <0.0001 2.58 (1.80–3.69)
 NASHa vs. control 0.39 vs. 0.24 0.011 1.96 (1.17–3.29) 0.023 1.86 (1.09–3.18)
 NASHb vs. control 0.52 vs. 0.24 <0.0001 3.02 (2.02–4.50) <0.0001 2.99 (1.99–4.50)
Simple steatosis as reference
All NASH vs. simple steatosis 0.48 vs. 0.35 0.083 1.63 (0.94–2.81)
 NASHa vs. simple steatosis 0.39 vs. 0.35 0.6 1.20 (0.61–2.38)
 NASHb vs. simple steatosis 0.52 vs. 0.35 0.035 1.85 (1.05–3.26)
NASH a as reference
NASHb vs. NASHa 0.52 vs 0.39 0.088 1.62 (0.93–2.81)

CI confident interval, OR odds ratio, NAFLD non-alcoholic fatty liver disease, NASH non-alcoholic steatohepatitis, NASH a non-alcoholic steatohepatitis without significant fibrosis, NASH b non-alcoholic steatohepatitis with significant fibrosis